Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Silvia Rota, Iro Boura, Lucia Batzu, Nataliya Titova, Peter Jenner, Cristian Falup-Pecurariu & K Ray Chaudhuri. (2020) ‘Dopamine agonist Phobia’ in Parkinson’s disease: when does it matter? Implications for non-motor symptoms and personalized medicine. Expert Review of Neurotherapeutics 20:9, pages 953-965.
Read now
Read now
Francesc Valldeoriola, Antonio Salvador, José Maria Gómez-Arguelles, José Marey, Miguel Moya, Ángel Ayuga & Francisco Ramírez. (2018) The effects of transdermal rotigotine on non-motor symptoms of Parkinson's disease: a multicentre, observational, retrospective, post-marketing study. International Journal of Neuroscience 128:4, pages 369-375.
Read now
Read now
Fabrizio Stocchi, Margherita Torti & Chiara Fossati. (2016) Advances in dopamine receptor agonists for the treatment of Parkinson’s disease. Expert Opinion on Pharmacotherapy 17:14, pages 1889-1902.
Read now
Read now
Tigran Kesayan, Jessica D Shaw, Tracy M Jones, Joseph S Staffetti & Theresa A Zesiewicz. (2015) Critical appraisal of rotigotine transdermal system in management of Parkinson’s disease and restless legs syndrome – patient considerations. Degenerative Neurological and Neuromuscular Disease 5, pages 63-72.
Read now
Read now
Theresa A Zesiewicz & Pablo Martinez-Martin. (2013) Effects of rotigotine transdermal system on non-motor symptoms in Parkinson’s disease: an overview. Expert Review of Neurotherapeutics 13:12, pages 1329-1342.
Read now
Read now
Articles from other publishers (30)
Xiao-Zhong Jing, Hui-Jia Yang, Reyisha Taximaimaiti & Xiao-Ping Wang. (2023) Advances in the Therapeutic Use of Non-Ergot Dopamine Agonists in the
Treatment of Motor and Non-Motor Symptoms of Parkinson’s Disease. Current Neuropharmacology 21:5, pages 1224-1240.
Crossref
Crossref
Mubasher A. Qamar, Phoebe Tall, Daniel van Wamelen, Yi Min Wan, Katarina Rukavina, Anna Fieldwalker, Donna Matthew, Valentina Leta, Kirsty Bannister & Kallol Ray Chaudhuri. 2023.
Kirsty Bannister, Rory V. Smith, Patrick Wilkins & Tatum M. Cummins. (2021) Towards optimising experimental quantification of persistent pain in Parkinson’s disease using psychophysical testing. npj Parkinson's Disease 7:1.
Crossref
Crossref
Vanessa Raeder, Iro Boura, Valentina Leta, Peter Jenner, Heinz Reichmann, Claudia Trenkwalder, Lisa Klingelhoefer & K. Ray Chaudhuri. (2021) Rotigotine Transdermal Patch for Motor and Non-motor Parkinson’s Disease: A Review of 12 Years’ Clinical Experience. CNS Drugs 35:2, pages 215-231.
Crossref
Crossref
Keke Li, Yijia Zhang, Enming Tian, Zikai Liu, Tian Wang & Fenghua Fu. (2020) The Effect of Rotigotine Extended-Release Microspheres Alone or With Celecoxib on the Inflammatory Pain. Frontiers in Pharmacology 11.
Crossref
Crossref
Katarina Rukavina, Valentina Leta, Carolina Sportelli, Yazead Buhidma, Susan Duty, Marzia Malcangio & Kallol Ray Chaudhuri. (2019) Pain in Parkinson's disease: new concepts in pathogenesis and treatment. Current Opinion in Neurology 32:4, pages 579-588.
Crossref
Crossref
James E. Frampton. (2019) Rotigotine Transdermal Patch: A Review in Parkinson’s Disease. CNS Drugs 33:7, pages 707-718.
Crossref
Crossref
Margherita Torti, Daniele Bravi, Laura Vacca & Fabrizio Stocchi. (2019) Are All Dopamine Agonists Essentially the Same?. Drugs 79:7, pages 693-703.
Crossref
Crossref
A. Antonini, M. Tinazzi, G. Abbruzzese, A. Berardelli, K. R. Chaudhuri, G. Defazio, J. Ferreira, P. Martinez-Martin, C. Trenkwalder & O. Rascol. (2018) Pain in Parkinson's disease: facts and uncertainties. European Journal of Neurology 25:7, pages 917-e69.
Crossref
Crossref
Roongroj Bhidayasiri & Claudia Trenkwalder. (2018) Getting a good night sleep? The importance of recognizing and treating nocturnal hypokinesia in Parkinson’s disease. Parkinsonism & Related Disorders 50, pages 10-18.
Crossref
Crossref
Jing Shi, Jinzhou Tian, Ting Li, Bin Qin, Dongsheng Fan, Jingnian Ni, Mingqing Wei, Xuekai Zhang, Na Liu, Jianping Liu, Yumeng Li, Weiwei Liu & Yongyan Wang. (2017) Efficacy and safety of SQJZ herbal mixtures on nonmotor symptoms in Parkinson disease patients. Medicine 96:50, pages e8824.
Crossref
Crossref
J. Andrew Albers, Pratap Chand & A. Michael Anch. (2017) Multifactorial sleep disturbance in Parkinson's disease. Sleep Medicine 35, pages 41-48.
Crossref
Crossref
Yan Wang, Yue-Chang Yang, Dan-Mei Lan, Hui -Juan Wu & Zhong-Xin Zhao. (2016) An observational clinical and video-polysomnographic study of the effects of rotigotine in sleep disorder in Parkinson’s disease. Sleep and Breathing 21:2, pages 319-325.
Crossref
Crossref
Marialuisa Gandolfi, Christian Geroin, Angelo Antonini, Nicola Smania & Michele Tinazzi. 2017. Nonmotor Parkinson’s: The Hidden Face - Management and the Hidden Face of Related Disorders. Nonmotor Parkinson’s: The Hidden Face - Management and the Hidden Face of Related Disorders
827
858
.
Maria João Forjaz, Carmen Rodriguez-Blazquez & Pablo Martinez-Martin. 2017. Movement Disorders Curricula. Movement Disorders Curricula
165
180
.
Tiago Martins Rodrigues, Ana Castro Caldas & Joaquim J. Ferreira. (2016) Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: Systematic review and meta-analysis. Parkinsonism & Related Disorders 27, pages 25-34.
Crossref
Crossref
Javier Pagonabarraga, Juan Marín-Lahoz & Jaime Kulisevsky. 2016. Parkinson's Disease. Parkinson's Disease
34
47
.
. 2016. Parkinson's Disease. Parkinson's Disease
1
92
.
Giovanna Calandra-Buonaura, Pietro Guaraldi, Andrea Doria, Stefano Zanigni, Stefania Nassetti, Valentina Favoni, Sabina Cevoli, Federica Provini & Pietro Cortelli. (2016) Rotigotine Objectively Improves Sleep in Parkinson’s Disease: An Open-Label Pilot Study with Actigraphic Recording. Parkinson's Disease 2016, pages 1-5.
Crossref
Crossref
Roongroj Bhidayasiri, Jirada Sringean & Chusak Thanawattano. (2016) Sensor-based evaluation and treatment of nocturnal hypokinesia in Parkinson's disease: An evidence-based review. Parkinsonism & Related Disorders 22, pages S127-S133.
Crossref
Crossref
Pablo Martinez-Martin, Carmen Rodriguez-Blazquez, Maria João Forjaz & Monica M. Kurtis. (2015) Impact of Pharmacotherapy on Quality of Life in Patients with Parkinson’s Disease. CNS Drugs 29:5, pages 397-413.
Crossref
Crossref
Krisztina Horváth, Zsuzsanna Aschermann, Péter Ács, Gabriella Deli, József Janszky, Sámuel Komoly, Kázmér Karádi, Márton Kovács, Attila Makkos, Béla Faludi & Norbert Kovács. (2015) Minimal Clinically Important Difference on Parkinson’s Disease Sleep Scale 2nd Version. Parkinson's Disease 2015, pages 1-8.
Crossref
Crossref
James Battista, Renee Monderer & Michael Thorpy. 2015. Disorders of Sleep and Circadian Rhythms in Parkinson's Disease. Disorders of Sleep and Circadian Rhythms in Parkinson's Disease
107
116
.
Jan Kassubek, Kallol Ray Chaudhuri, Theresa Zesiewicz, Erwin Surmann, Babak Boroojerdi, Kimberly Moran, Liesbet Ghys & Claudia Trenkwalder. (2014) Rotigotine transdermal system and evaluation of pain in patients with Parkinson’s disease: a post hocanalysis of the RECOVER study. BMC Neurology 14:1.
Crossref
Crossref
Arturo Benitez, Heather Edens, Jesse Fishman, Kimberly Moran & Mahnaz Asgharnejad. (2014) Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome. Annals of the New York Academy of Sciences 1329:1, pages 45-66.
Crossref
Crossref
Fabrizio Stocchi & Paola Stirpe. (2014) The relevance of dopaminergic level in nocturnal disability in Parkinson’s disease: implications of continuous dopaminergic stimulation at night to treat the symptoms. Journal of Neural Transmission 121:S1, pages 79-83.
Crossref
Crossref
Peter Jenner. (2013) Wearing Off, Dyskinesia, and the Use of Continuous Drug Delivery in Parkinson's Disease. Neurologic Clinics 31:3, pages S17-S35.
Crossref
Crossref
Maartje Louter, Ruud J.G. van Sloun, Dirk A.A. Pevernagie, Johan B.A.M. Arends, Pierre J. Cluitmans, Bastiaan R. Bloem & Sebastiaan Overeem. (2013) Subjectively impaired bed mobility in Parkinson disease affects sleep efficiency. Sleep Medicine 14:7, pages 668-674.
Crossref
Crossref
Giovanni Defazio, Angelo Gigante, Paola Mancino & Michele Tinazzi. (2012) The epidemiology of pain in Parkinson’s disease. Journal of Neural Transmission 120:4, pages 583-586.
Crossref
Crossref
K Ray Chaudhuri, Pablo Martinez-Martin, Per Odin & Angelo AntoniniPer Odin. 2011. Handbook of Non-Motor Symptoms in Parkinson's Disease. Handbook of Non-Motor Symptoms in Parkinson's Disease
57
66
.